206 related articles for article (PubMed ID: 17318900)
1. Blocking Wnt/LRP5 signaling by a soluble receptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma Saos-2 cells.
Guo Y; Zi X; Koontz Z; Kim A; Xie J; Gorlick R; Holcombe RF; Hoang BH
J Orthop Res; 2007 Jul; 25(7):964-71. PubMed ID: 17318900
[TBL] [Abstract][Full Text] [Related]
2. Frzb, a secreted Wnt antagonist, decreases growth and invasiveness of fibrosarcoma cells associated with inhibition of Met signaling.
Guo Y; Xie J; Rubin E; Tang YX; Lin F; Zi X; Hoang BH
Cancer Res; 2008 May; 68(9):3350-60. PubMed ID: 18451162
[TBL] [Abstract][Full Text] [Related]
3. Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-beta-catenin pathway.
Hoang BH; Kubo T; Healey JH; Yang R; Nathan SS; Kolb EA; Mazza B; Meyers PA; Gorlick R
Cancer Res; 2004 Apr; 64(8):2734-9. PubMed ID: 15087387
[TBL] [Abstract][Full Text] [Related]
4. Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness.
Zi X; Guo Y; Simoneau AR; Hope C; Xie J; Holcombe RF; Hoang BH
Cancer Res; 2005 Nov; 65(21):9762-70. PubMed ID: 16266997
[TBL] [Abstract][Full Text] [Related]
5. Dominant negative LRP5 decreases tumorigenicity and metastasis of osteosarcoma in an animal model.
Guo Y; Rubin EM; Xie J; Zi X; Hoang BH
Clin Orthop Relat Res; 2008 Sep; 466(9):2039-45. PubMed ID: 18566875
[TBL] [Abstract][Full Text] [Related]
6. N-cadherin interacts with axin and LRP5 to negatively regulate Wnt/beta-catenin signaling, osteoblast function, and bone formation.
Haÿ E; Laplantine E; Geoffroy V; Frain M; Kohler T; Müller R; Marie PJ
Mol Cell Biol; 2009 Feb; 29(4):953-64. PubMed ID: 19075000
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor receptor superfamily member 19 (TNFRSF19) regulates differentiation fate of human mesenchymal (stromal) stem cells through canonical Wnt signaling and C/EBP.
Qiu W; Hu Y; Andersen TE; Jafari A; Li N; Chen W; Kassem M
J Biol Chem; 2010 May; 285(19):14438-49. PubMed ID: 20223822
[TBL] [Abstract][Full Text] [Related]
8. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
[TBL] [Abstract][Full Text] [Related]
9. Wnt7b activates canonical signaling in epithelial and vascular smooth muscle cells through interactions with Fzd1, Fzd10, and LRP5.
Wang Z; Shu W; Lu MM; Morrisey EE
Mol Cell Biol; 2005 Jun; 25(12):5022-30. PubMed ID: 15923619
[TBL] [Abstract][Full Text] [Related]
10. Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling.
Cantiani L; Manara MC; Zucchini C; De Sanctis P; Zuntini M; Valvassori L; Serra M; Olivero M; Di Renzo MF; Colombo MP; Picci P; Scotlandi K
Cancer Res; 2007 Aug; 67(16):7675-85. PubMed ID: 17699771
[TBL] [Abstract][Full Text] [Related]
11. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling.
Enomoto M; Hayakawa S; Itsukushima S; Ren DY; Matsuo M; Tamada K; Oneyama C; Okada M; Takumi T; Nishita M; Minami Y
Oncogene; 2009 Sep; 28(36):3197-208. PubMed ID: 19561643
[TBL] [Abstract][Full Text] [Related]
12. Expression of LDL receptor-related protein 5 (LRP5) as a novel marker for disease progression in high-grade osteosarcoma.
Hoang BH; Kubo T; Healey JH; Sowers R; Mazza B; Yang R; Huvos AG; Meyers PA; Gorlick R
Int J Cancer; 2004 Mar; 109(1):106-11. PubMed ID: 14735475
[TBL] [Abstract][Full Text] [Related]
13. N-cadherin negatively regulates osteoblast proliferation and survival by antagonizing Wnt, ERK and PI3K/Akt signalling.
Haÿ E; Nouraud A; Marie PJ
PLoS One; 2009 Dec; 4(12):e8284. PubMed ID: 20011526
[TBL] [Abstract][Full Text] [Related]
14. Cross-talk between Wnt signaling pathways in human mesenchymal stem cells leads to functional antagonism during osteogenic differentiation.
Baksh D; Boland GM; Tuan RS
J Cell Biochem; 2007 Aug; 101(5):1109-24. PubMed ID: 17546602
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of the WNT5A Alternative Promoter B Is Associated with DNA Methylation and Histone Modification in Osteosarcoma Cell Lines U2OS and SaOS-2.
Vaidya H; Rumph C; Katula KS
PLoS One; 2016; 11(3):e0151392. PubMed ID: 26978652
[TBL] [Abstract][Full Text] [Related]
16. Chimaphilin inhibits human osteosarcoma cell invasion and metastasis through suppressing the TGF-β1-induced epithelial-to-mesenchymal transition markers via PI-3K/Akt, ERK1/2, and Smad signaling pathways.
Dong F; Liu T; Jin H; Wang W
Can J Physiol Pharmacol; 2018 Jan; 96(1):1-7. PubMed ID: 28177668
[TBL] [Abstract][Full Text] [Related]
17. FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo.
Brun J; Dieudonné FX; Marty C; Müller J; Schüle R; Patiño-García A; Lecanda F; Fromigué O; Marie PJ
PLoS One; 2013; 8(1):e55034. PubMed ID: 23383046
[TBL] [Abstract][Full Text] [Related]
18. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling.
Li X; Zhang Y; Kang H; Liu W; Liu P; Zhang J; Harris SE; Wu D
J Biol Chem; 2005 May; 280(20):19883-7. PubMed ID: 15778503
[TBL] [Abstract][Full Text] [Related]
19. Functional analysis of disease-associated polymorphism LRP5.Q89R.
Mao W; Wordinger RJ; Clark AF
Mol Vis; 2011 Apr; 17():894-902. PubMed ID: 21528003
[TBL] [Abstract][Full Text] [Related]
20. Critical role of Wnt5a-Ror2 signaling in motility and invasiveness of carcinoma cells following Snail-mediated epithelial-mesenchymal transition.
Ren D; Minami Y; Nishita M
Genes Cells; 2011 Mar; 16(3):304-15. PubMed ID: 21342370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
